EcoDrugPlus

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSCCRG00000022848
Gene Symbol: NT5E
1 Cross references
203 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSCCRG00000008343
Gene Symbol: NT5E
1 Cross references
203 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1d, G Protein-Coupled

Ensembl ID : ENSCCRG00000059245
Gene Symbol: HTR1D
1 Cross references
66 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSCCRG00000035197
Gene Symbol: HTR2B
1 Cross references
200 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSCCRG00000057644
Gene Symbol: HTR2B
1 Cross references
200 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSCCRG00000019463
Gene Symbol: HTR2CL1
1 Cross references
198 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSCCRG00000019458
Gene Symbol: HTR2CL1
1 Cross references
198 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate A

Ensembl ID : ENSCCRG00000000787
Gene Symbol: HTR5AA
1 Cross references
198 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate A

Ensembl ID : ENSCCRG00000036343
Gene Symbol: HTR5AA
1 Cross references
200 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate B

Ensembl ID : ENSCCRG00000058331
Gene Symbol: HTR5AB
1 Cross references
199 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate B

Ensembl ID : ENSCCRG00000011036
Gene Symbol: HTR5AB
1 Cross references
199 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSCCRG00000026413
Gene Symbol: HTR1A
1 Cross references
136 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).